Millipore Sigma Vibrant Logo
Attenzione: Ci siamo trasferiti. Non è più possibile acquistare i prodotti Merck Millipore nel sito MerckMillipore.comPer saperne di più

251010 1-β-D-Arabinofuranosylcytosine - CAS 147-94-4 - Calbiochem

Anticancer, antiviral agent that is especially effective against leukemias.

1-β-D-Arabinofuranosylcytosine - CAS 147-94-4 - Calbiochem: MSDS (material safety data sheet) o SDS, certificato d’analisi (CoA) e certificato di qualità (CoQ), dossier, brochure e altri documenti disponibili.

Sinonimi: Ara-C, Cytarabine, Cytosine Arabinoside

Primary Target: Anticancer, antiviral agent that is especially effective against leukemias
251010
Purchase on Sigma-Aldrich

Panoramica

Replacement Information

Tabella delle specifiche principali

CAS #Empirical Formula
147-94-4C₉H₁₃N₃O₅

Products

Numero di catalogoConfezionamento Qtà/conf
251010-1GM Fiala di plastica 1 gm
Description
OverviewAnticancer, antiviral agent that is especially effective against leukemias. Induces apoptosis in human myeloid leukemia cells and in rat sympathetic neurons. Induces G1/S phase cell cycle arrest.
Catalogue Number251010
Brand Family Calbiochem®
SynonymsAra-C, Cytarabine, Cytosine Arabinoside
References
ReferencesZarilli, R., et al. 1999. Gastroenterology 116, 1358.
Dessi, F., et al. 1995. J. Neurochem. 64, 1980.
Grant, S., et al. 1994. Oncol. Res. 6, 87.
Greenberg, A.L., et al. 1994. Cancer 74, 1261.
Perrino, F.W., et al. 1997. J. Biol. Chem. 269, 16357.
Tomkins, C.E., et al. 1994. J. Cell Sci. 107, 1499.
Taddie, J.A., and Traktman, P. 1993. J. Virol. 67, 4323.
Brach, M.A., et al. 1992. Mol. Pharmacol. 41, 60.
Este, E., et al. 1992. Blood 79, 2246.
Owens, J.K., et al. 1992. Cancer Res. 52, 2389.
Product Information
CAS number147-94-4
ATP CompetitiveN
FormWhite solid
Hill FormulaC₉H₁₃N₃O₅
Chemical formulaC₉H₁₃N₃O₅
ReversibleN
Structure formula ImageStructure formula Image
Quality LevelMQ100
Applications
Biological Information
Primary TargetAnticancer, antiviral agent that is especially effective against leukemias
Purity≥98% by HPLC
Physicochemical Information
Cell permeableN
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
RTECSHA5425000
Safety Information
R PhraseR: 20/21/22-36/37/38-43-61

Harmful by inhalation, in contact with skin and if swallowed.
Irritating to eyes, respiratory system and skin.
May cause sensitization by skin contact.
May cause harm to the unborn child.
S PhraseS: 22-36-45

Do not breathe dust.
Wear suitable protective clothing.
In case of accident or if you feel unwell, seek medical advice immediately (show the label where possible).
Product Usage Statements
Storage and Shipping Information
Ship Code Ambient Temperature Only
Toxicity Harmful & Carcinogenic / Teratogenic
Storage +2°C to +8°C
Do not freeze Ok to freeze
Special InstructionsFollowing reconstitution, aliquot and freeze (-70°C). Stock solutions are stable for up to 6 months at -70°C.
Packaging Information
Transport Information
Supplemental Information
Specifications
Global Trade Item Number
Numero di catalogo GTIN
251010-1GM 04055977199192

Documentation

1-β-D-Arabinofuranosylcytosine - CAS 147-94-4 - Calbiochem MSDS

Titolo

Scheda di sicurezza (MSDS) 

1-β-D-Arabinofuranosylcytosine - CAS 147-94-4 - Calbiochem Certificati d'Analisi

TitoloNumero di lotto
251010

Riferimenti bibliografici

Panoramica delle referenze
Zarilli, R., et al. 1999. Gastroenterology 116, 1358.
Dessi, F., et al. 1995. J. Neurochem. 64, 1980.
Grant, S., et al. 1994. Oncol. Res. 6, 87.
Greenberg, A.L., et al. 1994. Cancer 74, 1261.
Perrino, F.W., et al. 1997. J. Biol. Chem. 269, 16357.
Tomkins, C.E., et al. 1994. J. Cell Sci. 107, 1499.
Taddie, J.A., and Traktman, P. 1993. J. Virol. 67, 4323.
Brach, M.A., et al. 1992. Mol. Pharmacol. 41, 60.
Este, E., et al. 1992. Blood 79, 2246.
Owens, J.K., et al. 1992. Cancer Res. 52, 2389.
Scheda tecnica

Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

Revision05-April-2019 JSW
SynonymsAra-C, Cytarabine, Cytosine Arabinoside
DescriptionCytosine analog that acts as a potent inhibitor of eukaryotic cellular and viral replicative DNA synthesis. AraCTP, formed by intracellular phosphorylation of AraC, is utilized as a substrate by DNA polymerases, which incorporate AraCMP residues into DNA. Incorporated 3'-terminal AraCMP residues inhibit further DNA synthesis by impeding chain elongation by DNA polymerase. AraC is used clinically in the treatment of various cancers, particularly leukemias and lymphomas. Also used to inhibit proliferation of cultured cells and replication of eukaryotic viruses (e.g. vaccinia virus, herpes simplex virus). Also shown to induce apoptosis in human myeloid leukemia cells and in post-mitotic rat sympathetic neurons.
FormWhite solid
CAS number147-94-4
RTECSHA5425000
Chemical formulaC₉H₁₃N₃O₅
Structure formulaStructure formula
Purity≥98% by HPLC
SolubilityH₂O (1 mM)
Storage +2°C to +8°C
Do Not Freeze Ok to freeze
Special InstructionsFollowing reconstitution, aliquot and freeze (-70°C). Stock solutions are stable for up to 6 months at -70°C.
Toxicity Harmful & Carcinogenic / Teratogenic
Merck USA index14, 2784
ReferencesZarilli, R., et al. 1999. Gastroenterology 116, 1358.
Dessi, F., et al. 1995. J. Neurochem. 64, 1980.
Grant, S., et al. 1994. Oncol. Res. 6, 87.
Greenberg, A.L., et al. 1994. Cancer 74, 1261.
Perrino, F.W., et al. 1997. J. Biol. Chem. 269, 16357.
Tomkins, C.E., et al. 1994. J. Cell Sci. 107, 1499.
Taddie, J.A., and Traktman, P. 1993. J. Virol. 67, 4323.
Brach, M.A., et al. 1992. Mol. Pharmacol. 41, 60.
Este, E., et al. 1992. Blood 79, 2246.
Owens, J.K., et al. 1992. Cancer Res. 52, 2389.